Title: Nickel ions bind to HSP90β and enhance HIF-1α-mediated IL-8 expression.
Journal: Toxicology20180215
Title: Retinoic acid signalling is activated in the postischemic heart and may influence remodelling.
Journal: PloS one20120101
Title: Hypoxia-inducible factor inhibitors: a survey of recent patented compounds (2004 - 2010).
Journal: Expert opinion on therapeutic patents20110201
Title: Treatment with HIF-1alpha antagonist PX-478 inhibits progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in mice.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer20100701
Title: Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer.
Journal: Molecular cancer therapeutics20100701
Title: HIF-1alpha and cancer therapy.
Journal: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer20100101
Title: Hypoxia-inducible factor in cancer angiogenesis: structure, regulation and clinical perspectives.
Journal: Critical reviews in oncology/hematology20090501
Title: The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effects.
Journal: Molecular cancer therapeutics20090401
Title: PX-478, an inhibitor of hypoxia-inducible factor-1alpha, enhances radiosensitivity of prostate carcinoma cells.
Journal: International journal of cancer20081115
Title: Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha.
Journal: Molecular cancer therapeutics20080101
Title: Metabolite changes in HT-29 xenograft tumors following HIF-1alpha inhibition with PX-478 as studied by MR spectroscopy in vivo and ex vivo.
Journal: NMR in biomedicine20051101
Title: Hypoxia inducible factor-1: a novel target for cancer therapy.
Journal: Anti-cancer drugs20051001
Title: New drugs target hypoxia response in tumors.
Journal: Journal of the National Cancer Institute20050803
Title: Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478.
Journal: Neoplasia (New York, N.Y.)20050501
Title: Small molecule-mediated anti-cancer therapy via hypoxia-inducible factor-1 blockade.
Journal: Cancer biology & therapy20040601
Title: Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha.
Journal: Molecular cancer therapeutics20040301
Title: Palayoor ST, et al. PX-478, an inhibitor of hypoxia-inducible factor-1alpha, enhances radiosensitivity of prostate carcinoma cells. Int J Cancer. 2008 Nov 15;123(10):2430-2437.
Title: Agarwal S, et al. Inhibition of Hif1α prevents both trauma-induced and genetic heterotopic ossification. Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):E338-47.
